Credit Suisse Downgrades New Frontier Health (NFH) to Neutral
- Dow ends at record high, Nasdaq falls as tech slides
- Trump's Facebook (FB) Ban Upheld, Oversight Board Asks Company to Come Up With a 'Proportionate Response' Going Forward
- PayPal (PYPL) Tops Q1 EPS by 21c, Offers Q2 and FY Guidance
- Peloton (PTON) Plunges After Recalling All Treadmills, Analyst Says Will Negatively Impact Broader Tread Rollout
- T-Mobile (TMUS) Gains After Topping Q1 Consensus as 5G Story Accelerates, 'More to Come' Says Analyst
Credit Suisse analyst Jason Liu downgraded New Frontier Health (NYSE: NFH) from Outperform to Neutral with a price target of $12.00 (from $12.00).
Shares of New Frontier Health closed at $11.21 yesterday.
You May Also Be Interested In
- UPDATE: Craig-Hallum Downgrades Bottomline Technologies (EPAY) to Hold on Continued Bookings Declines
- Credit Suisse Downgrades Australia & New Zealand Banking Group (ANZ:AU) (ANZBY) to Neutral
- HSBC Downgrades Samsung Heavy Industries Co Ltd (010140:KS) to Reduce
Create E-mail Alert Related CategoriesDowngrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!